Electroporation for therapeutic DNA vaccination in patients

Medical Microbiology and Immunology

Volumn 204, Issue 1, 2015, Pages 131-135

  Sällberg, Matti ^a   Frelin, Lars ^a   Ahlén, Gustaf ^a   Sällberg Chen, Margaret ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

DNA vaccine; Electroporation; HBV; T cell; Therapeutic vaccine

Indexed keywords

DNA VACCINE;

DNA IMMUNIZATION; DRUG RESPONSE; DRUG UPTAKE; ELECTROPORATION; GENE GUN; GENE TARGETING; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO GENE TRANSFER; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS REPLICATION; IMMUNOLOGY; PROCEDURES; VACCINATION;

ELECTROPORATION; HUMANS; T-LYMPHOCYTES; VACCINATION; VACCINES, DNA;

EID: 84925501235     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-014-0384-8     Document Type: Review

References (24)

1. Ulmer JB et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745–1749
2. Calarota S et al (1998) Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351(9112):1320–1325
3. MacGregor RR et al (1998) First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 178:92–100
4. Wang R et al (1998) Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282:476–480
5. Neumann E, Rosenheck K (1972) Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 10:279–290
6. Neumann E et al (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1:841–845
7. Mir LM et al (1991) Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27:68–72
8. Belehradek M et al (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 72:3694–3700
9. Heller R (1995) Treatment of cutaneous nodules using electrochemotherapy. J Fla Med Assoc 82:147–150
10. Heller R et al (1996) Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77:964–971
11. Aihara H, Miyazaki J (1998) Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16:867–870
12. Mathiesen I (1999) Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 6:508–514
13. Ahlen G et al (2007) In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ cells. J Immunol 179:4741–4753
14. Luxembourg A et al (2006) Enhancement of immune responses to an HBV DNA vaccine by electroporation. Vaccine 24:4490–4493
15. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301–305
16. Schenten D, Medzhitov R (2011) The control of adaptive immune responses by the innate immune system. Adv Immunol 109:87–124
17. Bagarazzi ML (2012) Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Sci Transl Med 4:155ra138
18. Weiland O et al (2012) Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C. Mol Ther 21:1796–1805
19. Keane-Myers AM et al (2014) DNA electroporation of multi-agent vaccines conferring protection against select agent challenge: TriGrid delivery system. Methods Mol Biol 1121:325–336
20. Dolter KE et al (2011) Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation. Vaccine 29:795–803
21. Kalams SA et al (2013) Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. J Infect Dis 208:818–829
22. Vasan S et al (2011) In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS ONE 6:e19252
23. Klein TM et al (1987) High-velocity microprojectiles for delivering nucleic acids into living cells. Nature 327:70–73
24. Gill HS et al (2010) Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther 17:811–814